bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharma...
FDA Recall #D-0230-2018 — Class III — November 3, 2017
Product Description
bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC: 0378-2009-05
Reason for Recall
Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.
Recalling Firm
Mylan Pharmaceuticals Inc. — Morgantown, WV
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
1,414/500 count bottles
Distribution
Product was distributed nationwide in the USA
Code Information
Lot # 3077281, EXP 06-2018
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.